373 related articles for article (PubMed ID: 33858474)
21. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.
Lester-Coll NH; Dosoretz AP; Yu JB
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):563-8. PubMed ID: 24751412
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique.
Kelly PJ; Lin YB; Yu AY; Alexander BM; Hacker F; Marcus KJ; Weiss SE
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):95-101. PubMed ID: 21168282
[TBL] [Abstract][Full Text] [Related]
23. Post-operative stereotactic radiosurgery following excision of brain metastases: A systematic review and meta-analysis.
Akanda ZZ; Hong W; Nahavandi S; Haghighi N; Phillips C; Kok DL
Radiother Oncol; 2020 Jan; 142():27-35. PubMed ID: 31563407
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
25. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
26. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
27. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis.
Jensen CA; Chan MD; McCoy TP; Bourland JD; deGuzman AF; Ellis TL; Ekstrand KE; McMullen KP; Munley MT; Shaw EG; Urbanic JJ; Tatter SB
J Neurosurg; 2011 Jun; 114(6):1585-91. PubMed ID: 21166567
[TBL] [Abstract][Full Text] [Related]
28. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors.
Nahed BV; Alvarez-Breckenridge C; Brastianos PK; Shih H; Sloan A; Ammirati M; Kuo JS; Ryken TC; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E152-E155. PubMed ID: 30629227
[TBL] [Abstract][Full Text] [Related]
29. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
[TBL] [Abstract][Full Text] [Related]
30. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
31. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
[TBL] [Abstract][Full Text] [Related]
32. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
33. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ; Olson JJ; Curran WJ; Shu HG; Crocker IR; Prabhu RS
J Neurooncol; 2017 Feb; 131(3):611-618. PubMed ID: 28000105
[TBL] [Abstract][Full Text] [Related]
34. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors.
Elaimy AL; Mackay AR; Lamoreaux WT; Fairbanks RK; Demakas JJ; Cooke BS; Lee CM
World Neurosurg; 2011; 75(5-6):673-83. PubMed ID: 21704935
[TBL] [Abstract][Full Text] [Related]
37. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Mahajan A; Ahmed S; McAleer MF; Weinberg JS; Li J; Brown P; Settle S; Prabhu SS; Lang FF; Levine N; McGovern S; Sulman E; McCutcheon IE; Azeem S; Cahill D; Tatsui C; Heimberger AB; Ferguson S; Ghia A; Demonte F; Raza S; Guha-Thakurta N; Yang J; Sawaya R; Hess KR; Rao G
Lancet Oncol; 2017 Aug; 18(8):1040-1048. PubMed ID: 28687375
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Rogers S; Baumert B; Blanck O; Böhmer D; Boström J; Engenhart-Cabillic R; Ermis E; Exner S; Guckenberger M; Habermehl D; Hemmatazad H; Henke G; Lohaus F; Lux S; Mai S; Minasch D; Rezazadeh A; Steffal C; Temming S; Wittig A; Zweifel C; Riesterer O; Combs SE
Strahlenther Onkol; 2022 Oct; 198(10):919-925. PubMed ID: 36006436
[TBL] [Abstract][Full Text] [Related]
39. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
Prabhu R; Shu HK; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e61-6. PubMed ID: 22516387
[TBL] [Abstract][Full Text] [Related]
40. The role of whole-brain radiation therapy after stereotactic radiation surgery for brain metastases.
Hasan S; Shah AH; Bregy A; Albert T; Markoe A; Stoyanova R; Thambuswamy M; Komotar RJ
Pract Radiat Oncol; 2014; 4(5):306-315. PubMed ID: 25194099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]